Login Register Cart 0
Generic placeholder image

Current Radiopharmaceuticals

Editor-in-Chief

ISSN (Print): 1874-4710
ISSN (Online): 1874-4729

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy

Author(s): Marco Spadafora*, Laura Evangelista, Salvatore Fiordoro, Francesco Porcaro, Marilena Sicignano and Luigi Mansi

Volume 13, Issue 3, 2020

Page: [243 - 248] Pages: 6

DOI: 10.2174/1874471013666200318142210

Abstract

Purpose: The Italian Tailored Assessment of Lung Indeterminate Accidental Nodule (ITALIAN) trial is a trial drawn to determine the performance of 18F-FDG-PET/CT in patients with solitary pulmonary nodules (SPN), stratified for a different kind of risk. An additional end-point was to compare the diagnostic information and estimated dosimetry, provided by a segmental PET/CT (s-PET/CT) acquisition instead of a whole body PET/CT (wb-PET/CT), in order to evaluate if segmental thoracic PET/CT can be used in patients with SPN.

Methods: 18F-FDG PET/CT of 502 patients, stratified for pre-test cancer risk, was retrospectively analyzed. FDG uptake in SPN was assessed by a 4-point scoring (4PS) system and a semiquantitative analysis using the ratio between SUVmax in SPN and SUVmean in mediastinal blood pool (BP), and between SUVmax in SPN and SUVmean in the liver (L). Histopathology and/or follow-up data were used as a standard of reference. Data obtained on the thoracic part of wb-PET/CT, defined as s - PET/CT, were compared with those deriving from wb-PET/CT.

Results: SPNs were malignant in 180 patients (36%), benign in 175 (35%), and indeterminate in 147 (29%). The 355 patients diagnosed with a definitive SPN nature (malignant or benign) were considered for the analysis of PET performance. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values, and accuracy were 85.6%, 85.7%, 86%, 85.2%, and 85.6%, respectively. Sensitivity and PPV were higher in intermediate and high-risk patients.

18F-FDG uptake indicative of thoracic and extra-thoracic lesions was detectable in 13% and 3% of the patients. Compared to wb-PET/CT, s-PET/CT could save about 2/3 of 18F-FDG dose, radiation exposure or scan-time, without affecting the clinical impact of PET/CT.

Conclusion: In patients with SPN, the pre-test likelihood of malignancy stratification allows to better define PET clinical setting and its diagnostic power. In subjects with low-intermediate pre-test likelihood of malignancy, s-PET/CT might be planned in advance. The adoption of this segmental strategy could reduce radiation exposure, scan-time, and might allow individually targeted protocols.

Keywords: Lung cancer, single pulmonary nodules, likelihood, FDG, PET/CT.

« Previous Next »
Graphical Abstract

[1]
Hansell, D.M.; Bankier, A.A.; MacMahon, H.; McLoud, T.C.; Müller, N.L.; Remy, J. Fleischner Society: glossary of terms for thoracic imaging. Radiology, 2008, 246(3), 697-722.
[http://dx.doi.org/10.1148/radiol.2462070712] [PMID: 18195376]
[2]
Callister, M.E.J.; Baldwin, D.R.; Akram, A.R.; Barnard, S.; Cane, P.; Draffan, J.; Franks, K.; Gleeson, F.; Graham, R.; Malhotra, P.; Prokop, M.; Rodger, K.; Subesinghe, M.; Waller, D.; Woolhouse, I. British Thoracic Society Pulmonary Nodule Guideline Development Group. British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the investigation and management of pul-monary nodules. Thorax, 2015, 70(Suppl. 2), ii1-ii54.
[http://dx.doi.org/10.1136/thoraxjnl-2015-207168] [PMID: 26082159]
[3]
Port, J.L.; Kent, M.S.; Korst, R.J.; Libby, D.; Pasmantier, M.; Altorki, N.K. Tumor size predicts survival within stage IA non-small cell lung cancer. Chest, 2003, 124(5), 1828-1833.
[http://dx.doi.org/10.1378/chest.124.5.1828] [PMID: 14605056]
[4]
Goldstraw, P.; Crowley, J.J. The International Association for the Study of Lung Cancer international staging project on lung cancer. J. Thorac. Oncol., 2006, 1, 281-286.
[http://dx.doi.org/10.1097/01243894-200605000-00002]
[5]
Sim, Y.T.; Poon, F.W. Imaging of solitary pulmonary nodule-a clinical review. Quant. Imaging Med. Surg., 2013, 3(6), 316-326.
[PMID: 24404446]
[6]
Gould, M.K.; Donington, J.; Lynch, W.R. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and man-agement of lung cancerAmerican College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest, 3rd ed;; , 2013, 143, . (suppl5) 93-120
[7]
MacMahon, H.; Austin, J.H.; Gamsu, G.; Herold, C.J.; Jett, J.R.; Naidich, D.P.; Patz, E.F., Jr; Swensen, S.J. Fleischner Society. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology, 2005, 237(2), 395-400.
[http://dx.doi.org/10.1148/radiol.2372041887] [PMID: 16244247]
[8]
Aberle, D.R.; Adams, A.M.; Berg, C.D.; Black, W.C.; Clapp, J.D.; Fagerstrom, R.M.; Gareen, I.F.; Gatsonis, C.; Marcus, P.M.; Sicks, J.D. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med., 2011, 365(5), 395-409.
[http://dx.doi.org/10.1056/NEJMoa1102873] [PMID: 21714641]
[9]
Tasdemir, B.; Urakci, Z.; Dostbil, Z.; Unal, K.; Simsek, F.S.; Teke, F.; Goya, C. Effectiveness of the addition of the brain region to the FDG-PET/CT imaging area in patients with suspected or diagnosed lung cancer. Radiol. Med. (Torino), 2016, 121(3), 218-224.
[http://dx.doi.org/10.1007/s11547-015-0597-y] [PMID: 26541882]
[10]
Spadafora, M.; Pace, L.; Mansi, L. Segmental 18F-FDG-PET/CT in a single pulmonary nodule: a better cost/effectiveness strategy. Eur. J. Nucl. Med. Mol. Imaging, 2017, 44(1), 1-4.
[http://dx.doi.org/10.1007/s00259-016-3532-0] [PMID: 27695909]
[11]
Spadafora, M.; Evangelista, L.; Gridelli, C.; Cuocolo, A. Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET? Eur. J. Radiol., 2017, 90, 188-191.
[http://dx.doi.org/10.1016/j.ejrad.2017.03.001] [PMID: 28583632]
[12]
Spadafora, M.; Pace, L.; Mansi, L. The delicate balance between present and future. Eur. J. Nucl. Med. Mol. Imaging, 2017, 44(2), 346-347.
[http://dx.doi.org/10.1007/s00259-016-3579-y] [PMID: 27909768]
[13]
Gould, M.K.; Maclean, C.C.; Kuschner, W.G.; Rydzak, C.E.; Owens, D.K. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA, 2001, 285(7), 914-924.
[http://dx.doi.org/10.1001/jama.285.7.914] [PMID: 11180735]
[14]
Cronin, P.; Dwamena, B.A.; Kelly, A.M.; Carlos, R.C. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology, 2008, 246(3), 772-782.
[http://dx.doi.org/10.1148/radiol.2463062148] [PMID: 18235105]
[15]
Fletcher, J.W.; Kymes, S.M.; Gould, M.; Alazraki, N.; Coleman, R.E.; Lowe, V.J.; Marn, C.; Segall, G.; Thet, L.A.; Lee, K.V.A. SNAP Cooperative Studies Group. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J. Nucl. Med., 2008, 49(2), 179-185.
[http://dx.doi.org/10.2967/jnumed.107.044990] [PMID: 18199626]
[16]
van der Vos, C.S.; Koopman, D.; Rijnsdorp, S.; Arends, A.J.; Boellaard, R.; van Dalen, J.A.; Lubberink, M.; Willemsen, A.T.M.; Visser, E.P. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET. Eur. J. Nucl. Med. Mol. Imaging, 2017, 44(Suppl. 1), 4-16.
[http://dx.doi.org/10.1007/s00259-017-3727-z] [PMID: 28687866]
[17]
Evangelista, L.; Cuocolo, A.; Pace, L.; Mansi, L.; Del Vecchio, S.; Miletto, P.; Sanfilippo, S.; Pellegrino, S.; Guerra, L.; Pepe, G.; Peluso, G.; Salvatore, M.; Galicchio, R.; Zuffante, M.; Annunziata, S.; Farsad, M.; Chiaravalloti, A.; Spadafora, M. Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial. Eur. J. Nucl. Med. Mol. Imaging, 2018, 45(11), 1898-1907.
[http://dx.doi.org/10.1007/s00259-018-4016-1] [PMID: 29736699]
[18]
McWilliams, A.; Tammemagi, M.C.; Mayo, J.R.; Roberts, H.; Liu, G.; Soghrati, K.; Yasufuku, K.; Martel, S.; Laberge, F.; Gingras, M.; Atkar-Khattra, S.; Berg, C.D.; Evans, K.; Finley, R.; Yee, J.; English, J.; Nasute, P.; Goffin, J.; Puksa, S.; Stewart, L.; Tsai, S.; Johnston, M.R.; Manos, D.; Nicholas, G.; Goss, G.D.; Seely, J.M.; Amjadi, K.; Tremblay, A.; Burrowes, P.; MacEachern, P.; Bhatia, R.; Tsao, M.S.; Lam, S. Probability of cancer in pulmonary nodules detected on first screening CT. N. Engl. J. Med., 2013, 369(10), 910-919.
[http://dx.doi.org/10.1056/NEJMoa1214726] [PMID: 24004118]
[19]
Li, W.; Pang, H.; Liu, Q.; Zhou, J. The role of 18F-FDG PET or 18F-FDG-PET/CT in the evaluation of solitary pulmonary nodules. Eur. J. Radiol., 2015, 84(10), 2032-2037.
[http://dx.doi.org/10.1016/j.ejrad.2015.06.008] [PMID: 26094866]
[20]
http://www.icrp.org/docs/ICRP%20Strategic%20Plan%202016-2020.pdf
[21]
Sullivan, R.; Peppercorn, J.; Sikora, K.; Zalcberg, J.; Meropol, N.J.; Amir, E.; Khayat, D.; Boyle, P.; Autier, P.; Tannock, I.F.; Fojo, T.; Siderov, J.; Williamson, S.; Camporesi, S.; McVie, J.G.; Purushotham, A.D.; Naredi, P.; Eggermont, A.; Brennan, M.F.; Steinberg, M.L.; De Ridder, M.; McCloskey, S.A.; Verellen, D.; Roberts, T.; Storme, G.; Hicks, R.J.; Ell, P.J.; Hirsch, B.R.; Carbone, D.P.; Schulman, K.A.; Catchpole, P.; Taylor, D.; Geissler, J.; Brinker, N.G.; Meltzer, D.; Kerr, D.; Aapro, M. Delivering affordable cancer care in high-income countries. Lancet Oncol., 2011, 12(10), 933-980.
[http://dx.doi.org/10.1016/S1470-2045(11)70141-3] [PMID: 21958503]
[22]
Iglehart, J.K. Health insurers and medical-imaging policy--a work in progress. N. Engl. J. Med., 2009, 360(10), 1030-1037.
[http://dx.doi.org/10.1056/NEJMhpr0808703] [PMID: 19264694]
[23]
Delbeke, D.; Coleman, R.E.; Guiberteau, M.J.; Brown, M.L.; Royal, H.D.; Siegel, B.A.; Townsend, D.W.; Berland, L.L.; Parker, J.A.; Hubner, K.; Stabin, M.G.; Zubal, G.; Kachelriess, M.; Cronin, V.; Holbrook, S. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J. Nucl. Med., 2006, 47(5), 885-895.
[PMID: 16644760]
[24]
Hustinx, R. How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol. Eur. J. Nucl. Med. Mol. Imaging, 2017, 44(1), 5-7.
[http://dx.doi.org/10.1007/s00259-016-3511-5] [PMID: 27624189]
[25]
Boellaard, R.; Delgado-Bolton, R.; Oyen, W.J.G.; Giammarile, F.; Tatsch, K.; Eschner, W.; Verzijlbergen, F.J.; Barrington, S.F.; Pike, L.C.; Weber, W.A.; Stroobants, S.; Delbeke, D.; Donohoe, K.J.; Holbrook, S.; Graham, M.M.; Testanera, G.; Hoekstra, O.S.; Zijlstra, J.; Visser, E.; Hoekstra, C.J.; Pruim, J.; Willemsen, A.; Arends, B.; Kotzerke, J.; Bockisch, A.; Beyer, T.; Chiti, A.; Krause, B.J. European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur. J. Nucl. Med. Mol. Imaging, 2015, 42(2), 328-354.
[http://dx.doi.org/10.1007/s00259-014-2961-x] [PMID: 25452219]
[26]
Patz, E.F., Jr; Pinsky, P.; Gatsonis, C.; Sicks, J.D.; Kramer, B.S.; Tammemägi, M.C. Over-diagnosis manuscript writing team over-diagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern. Med., 2014, 174, 269-274.
[http://dx.doi.org/10.1001/jamainternmed.2013.12738] [PMID: 24322569]

Rights & Permissions Print Cite
Article Metrics
22
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy